Volasertib, Boehringer Ingelheim's Investigational Oncology Compound, is Granted Orphan Drug Designation for Acute Myeloid Leukemia in the U.S. and EU

Apr 17, 2014, 08:00 ET from Boehringer Ingelheim Pharmaceuticals, Inc.

$countyNameToPathMap.put("sp